i China Asset Management reduced its holdings in Sanlife Pharmaceutical (01530.HK) by 216,200 shares at a price of approximately HK$17.15 per share.

According to the Wise Finance APP, the latest data from the Hong Kong Stock Exchange shows that on June 2nd, Invesco Fund reduced its holdings of Sanlife Pharmaceuticals (01530.HK) by 2.162 million shares, with a price of 17.1455 Hong Kong dollars per share, totaling approximately 37.0686 million Hong Kong dollars. After the reduction, the latest number of shares held is approximately 178 million shares, with a latest shareholding ratio of 6.99%.